Synopsis
Synopsis
0
KDMF
0
Australia
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2-(2-chlorophenyl)-2-(methylamino)cyclohexanone
2. Calipsol
3. Calypsol
4. Ci 581
5. Ci-581
6. Ci581
7. Kalipsol
8. Ketalar
9. Ketamine
10. Ketanest
11. Ketaset
1. 1867-66-9
2. Vetalar
3. Ketaset
4. Ketalar
5. Ketamine Hcl
6. Ketanest
7. Ketolar
8. 2-(2-chlorophenyl)-2-(methylamino)cyclohexanone Hydrochloride
9. Cl 369
10. Cn-52,372-2
11. (+-)-ketamine Hydrochloride
12. Ci-581
13. Ketamine Hydrochloride Ciii
14. Ketamine (as Hydrochloride)
15. O18yuo0i83
16. Calipsol
17. Kalipsol
18. Ketavet
19. (+-)-2-(o-chlorophenyl)-2-(methylamino)cyclohexanone Hydrochloride
20. Cl-369
21. Dea No. 7285
22. Cn-523722
23. 2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one;hydrochloride
24. Cn-52372-2
25. Ketamine Chloride
26. Ketavet 100
27. Ketavet (veterinary)
28. Ci 581
29. Chebi:650657
30. Einecs 217-484-6
31. Unii-o18yuo0i83
32. Ketalar (tn)
33. Ketamini Hydrochloridum
34. Ketamine Hydrochloride [usan:usp:jan]
35. Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, Hydrochloride
36. Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, Hydrochloride, (+-)-
37. Ec 217-484-6
38. Chembl1714
39. Schembl26999
40. Dtxsid4040137
41. Ketamine Hydrochloride [mi]
42. 2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one Hydrochloride
43. Bcp25943
44. Ketamine Hydrochloride (jp17/usp)
45. Ketamine Hydrochloride [jan]
46. (+/-)-2-(o-chlorophenyl)-2-(methylamino)cyclohexanone Hydrochloride
47. Ketamine Hydrochloride [usan]
48. Nsc116131
49. (+/-)-ketamine Hydrochloride, Solid
50. Ketamine Hydrochloride [vandf]
51. Akos005287313
52. Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, Hydrochloride, (+-)-
53. Ketamine Hydrochloride [mart.]
54. Ab02117
55. Ketamine Hydrochloride [who-dd]
56. Ketamine Hydrochloride [who-ip]
57. Nsc-116131
58. Ketamine Hydrochloride [green Book]
59. Db-044614
60. Db-048467
61. Ketamine Hydrochloride [ep Impurity]
62. Ketamine Hydrochloride [orange Book]
63. Ketamine Hydrochloride [ep Monograph]
64. Ketamine Hydrochloride Ciii [usp-rs]
65. Ketamine Hydrochloride [usp Monograph]
66. Ketamini Hydrochloridum [who-ip Latin]
67. C07843
68. D00711
69. 867k669
70. A813079
71. Q-201266
72. Q27105184
73. Ketamine Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)
74. 2-(2-chlorophenyl)-2-(methylamino)-1-cyclohexanone Hydrochloride
75. Ketamine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
76. Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, Hydrochloride (1:1)
77. Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, Hydrochloride, (+/-)-
78. Ketamine (+-)-2-(o-chlorophenyl)-2-(methylamino)cyclohexanonehydrochloride
79. Ketamine Hydrochloride Solution, 1.0 Mg/ml In Methanol (as Free Base), Ampule Of 1 Ml, Certified Reference Material
Molecular Weight | 274.18 g/mol |
---|---|
Molecular Formula | C13H17Cl2NO |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 2 |
Exact Mass | 273.0687196 g/mol |
Monoisotopic Mass | 273.0687196 g/mol |
Topological Polar Surface Area | 29.1 Ų |
Heavy Atom Count | 17 |
Formal Charge | 0 |
Complexity | 269 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Ketalar |
Drug Label | Ketalar is a nonbarbiturate anesthetic chemically designated dl 2-(0-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride. It is formulated as a slightly acid (pH 3.5-5.5) sterile solution for intravenous or intramuscular injection in concentrat... |
Active Ingredient | Ketamine hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 10mg base/ml; eq 50mg base/ml; eq 100mg base/ml |
Market Status | Prescription |
Company | Par Sterile Products |
2 of 4 | |
---|---|
Drug Name | Ketamine hydrochloride |
PubMed Health | Ketamine (Injection) |
Drug Label | Ketamine hydrochloride is a nonbarbiturate anesthetic chemically designated dl 2-(0-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride. It is formulated as a slightly acid (pH 3.5-5.5) sterile solution for intravenous or intramuscular injectio... |
Active Ingredient | Ketamine hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 10mg base/ml; eq 50mg base/ml; eq 100mg base/ml |
Market Status | Prescription |
Company | Hospira; Mylan Institutional; Eurohlth Intl |
3 of 4 | |
---|---|
Drug Name | Ketalar |
Drug Label | Ketalar is a nonbarbiturate anesthetic chemically designated dl 2-(0-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride. It is formulated as a slightly acid (pH 3.5-5.5) sterile solution for intravenous or intramuscular injection in concentrat... |
Active Ingredient | Ketamine hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 10mg base/ml; eq 50mg base/ml; eq 100mg base/ml |
Market Status | Prescription |
Company | Par Sterile Products |
4 of 4 | |
---|---|
Drug Name | Ketamine hydrochloride |
PubMed Health | Ketamine (Injection) |
Drug Label | Ketamine hydrochloride is a nonbarbiturate anesthetic chemically designated dl 2-(0-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride. It is formulated as a slightly acid (pH 3.5-5.5) sterile solution for intravenous or intramuscular injectio... |
Active Ingredient | Ketamine hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 10mg base/ml; eq 50mg base/ml; eq 100mg base/ml |
Market Status | Prescription |
Company | Hospira; Mylan Institutional; Eurohlth Intl |
Anesthetics, Dissociative
Intravenous anesthetics that induce a state of sedation, immobility, amnesia, and marked analgesia. Subjects may experience a strong feeling of dissociation from the environment. The condition produced is similar to NEUROLEPTANALGESIA, but is brought about by the administration of a single drug. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) (See all compounds classified as Anesthetics, Dissociative.)
Analgesics
Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)
Excitatory Amino Acid Antagonists
Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. (See all compounds classified as Excitatory Amino Acid Antagonists.)
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-11-05
Pay. Date : 2019-10-28
DMF Number : 7686
Submission : 1988-09-22
Status : Active
Type : II
Certificate Number : CEP 2005-281 - Rev 02
Issue Date : 2024-03-11
Type : Chemical
Substance Number : 1020
Status : Valid
Registration Number : 218MF10980
Registrant's Address : Raiffeisenstrasse 4, D-77933 Lahr Germany
Initial Date of Registration : 2006-12-01
Latest Date of Registration :
NDC Package Code : 49169-1041
Start Marketing Date : 2024-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ASMF, BR, CA |
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-12-22
Pay. Date : 2022-12-20
DMF Number : 27921
Submission : 2014-01-15
Status : Active
Type : II
Certificate Number : CEP 2016-194 - Rev 01
Issue Date : 2024-05-07
Type : Chemical
Substance Number : 1020
Status : Valid
Date of Issue : 2022-06-29
Valid Till : 2025-07-02
Written Confirmation Number : WC-0218
Address of the Firm :
NDC Package Code : 61281-8000
Start Marketing Date : 2013-07-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : CA, ASMF, AU |
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37014
Submission : 2022-03-29
Status : Active
Type : II
Certificate Number : CEP 2022-157 - Rev 00
Issue Date : 2024-03-04
Type : Chemical
Substance Number : 1020
Status : Valid
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19082
Submission : 2005-12-16
Status : Active
Type : II
Certificate Number : R1-CEP 1998-125 - Rev 04
Issue Date : 2012-02-09
Type : Chemical
Substance Number : 1020
Status : Valid
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-06-09
Pay. Date : 2021-04-29
DMF Number : 35385
Submission : 2020-12-30
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-04-06
Pay. Date : 2015-04-16
DMF Number : 29094
Submission : 2015-04-14
Status : Active
Type : II
Certificate Number : R1-CEP 2015-037 - Rev 01
Issue Date : 2023-02-08
Type : Chemical
Substance Number : 1020
Status : Valid
NDC Package Code : 10920-597
Start Marketing Date : 2013-12-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5462
Submission : 1984-07-17
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22256
Submission : 2008-11-28
Status : Inactive
Type : II
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
GDUFA
DMF Review : Complete
Rev. Date : 2019-11-05
Pay. Date : 2019-10-28
DMF Number : 7686
Submission : 1988-09-22
Status : Active
Type : II
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
GDUFA
DMF Review : Complete
Rev. Date : 2022-12-22
Pay. Date : 2022-12-20
DMF Number : 27921
Submission : 2014-01-15
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2016-04-06
Pay. Date : 2015-04-16
DMF Number : 29094
Submission : 2015-04-14
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19082
Submission : 2005-12-16
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5462
Submission : 1984-07-17
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2021-06-09
Pay. Date : 2021-04-29
DMF Number : 35385
Submission : 2020-12-30
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22256
Submission : 2008-11-28
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37014
Submission : 2022-03-29
Status : Active
Type : II
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
Certificate Number : CEP 2005-281 - Rev 02
Status : Valid
Issue Date : 2024-03-11
Type : Chemical
Substance Number : 1020
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Certificate Number : CEP 2016-194 - Rev 01
Status : Valid
Issue Date : 2024-05-07
Type : Chemical
Substance Number : 1020
Certificate Number : R1-CEP 2015-037 - Rev 01
Status : Valid
Issue Date : 2023-02-08
Type : Chemical
Substance Number : 1020
Certificate Number : R1-CEP 1998-125 - Rev 04
Status : Valid
Issue Date : 2012-02-09
Type : Chemical
Substance Number : 1020
Certificate Number : R1-CEP 2007-362 - Rev 01
Status : Valid
Issue Date : 2014-11-27
Type : Chemical
Substance Number : 1020
Certificate Number : CEP 2022-157 - Rev 00
Status : Valid
Issue Date : 2024-03-04
Type : Chemical
Substance Number : 1020
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
Registration Number : 218MF10980
Registrant's Address : Raiffeisenstrasse 4, D-77933 Lahr Germany
Initial Date of Registration : 2006-12-01
Latest Date of Registration : 2021-12-09
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Ketamine Hydrochloride (BP/EP/USP)
Date of Issue : 2022-06-29
Valid Till : 2025-07-02
Written Confirmation Number : WC-0218
Address of the Firm : A-5/2, Late Parshuram Industrial Area, MIDC, Tal-Khed, Dist. Ratnagiri-415 722, ...
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
NDC Package Code : 49169-1041
Start Marketing Date : 2024-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
NDC Package Code : 54382-128
Start Marketing Date : 1989-08-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
NDC Package Code : 54382-114
Start Marketing Date : 1989-02-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
NDC Package Code : 61281-8000
Start Marketing Date : 2013-07-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 10920-701
Start Marketing Date : 2022-01-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 73377-250
Start Marketing Date : 2023-09-20
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 63275-9980
Start Marketing Date : 2010-10-08
End Marketing Date : 2025-12-01
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62991-1087
Start Marketing Date : 2009-06-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-0292
Start Marketing Date : 2002-07-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 82393-116
Start Marketing Date : 2021-02-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
VMF Number : 5368
Submission : 1991-07-15
Status : Inactive
Type : II
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
About the Company : Since its inception in 2003, Seqens has evolved into a global leader in pharmaceutical solutions and specialty ingredients. With a strong focus on customer support, Seqens assists ...
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
About the Company : Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Su...
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
About the Company : Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opp...
About the Company : Arevipharma GmbH is a modern manufacturer of active pharmaceutical ingredients and intermediates with more than 140 years of expertise. Our customers are generic and research-based...
About the Company : Arevipharma GmbH is a modern manufacturer of active pharmaceutical ingredients and intermediates with more than 140 years of expertise. Our customers are generic and research-based...
About the Company : BIOTECHNICA DWC LLC has carved a niche for itself in providing value added compliance, regulatory qualification, project management and GDP guidance services to pharma companies al...
About the Company : Globe Quimica S.A. is a major Brazilian API producer, GMP certificated by ANVISA, manufactures more than 20 different API's such as Antiretrovirals, Anxiolytic, Antidepressant, Ant...
About the Company : SB Pharma GmbH, with its headquarters in Cologne, is a leading company that has set itself the goal of offering pharmaceuticals, medical products and medical devices as well as a b...
About the Company : With over 85 years of experience, Uquifa provides comprehensive services supporting projects from proof of concept to commercial manufacturing. Uquifa’s business model is built o...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Reply
13 Apr 2024
Reply
04 Jan 2024
Reply
08 Dec 2023
Reply
13 Nov 2020
Reply
21 Aug 2019
Reply
18 Jul 2019
Reply
13 Jun 2019
Reply
13 Oct 2018
Reply
09 Oct 2018
Reply
08 Jun 2021
Reply
15 Apr 2021
Reply
09 Apr 2021
Reply
12 Nov 2020
Reply
18 Sep 2018
Reply
07 Feb 2018
Reply
31 Oct 2017
REF. STANDARDS & IMPURITIES
Ketamine Related Compound A (50 mg) (1-[(2-Ch...
CAS Number : 6740-87-0
Quantity Per Vial :
Price ($) : 805
Catalog Number : 1356020
Current Lot : R06470
Previous Lot : F0C118 (31-MAY-2018)
NDC Code :
Ketamine Hydrochloride CIII (250 mg)
CAS Number : 1867-66-9
Quantity Per Vial :
Price ($) : 305
Catalog Number : 1356009
Current Lot : I0J272
Previous Lot : H0E091 (31-MAY-2012)
NDC Code : 00216728505
ANALYTICAL
Product Code : NR30S05-2546WT
Classification : Optical isomers
Product Characteristics : N020605F
Category :
Description :
ABOUT THIS PAGE
63
PharmaCompass offers a list of Ketamine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ketamine Hydrochloride manufacturer or Ketamine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ketamine Hydrochloride manufacturer or Ketamine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Ketamine Hydrochloride API Price utilized in the formulation of products. Ketamine Hydrochloride API Price is not always fixed or binding as the Ketamine Hydrochloride Price is obtained through a variety of data sources. The Ketamine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ketanest manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ketanest, including repackagers and relabelers. The FDA regulates Ketanest manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ketanest API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ketanest manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ketanest supplier is an individual or a company that provides Ketanest active pharmaceutical ingredient (API) or Ketanest finished formulations upon request. The Ketanest suppliers may include Ketanest API manufacturers, exporters, distributors and traders.
click here to find a list of Ketanest suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ketanest DMF (Drug Master File) is a document detailing the whole manufacturing process of Ketanest active pharmaceutical ingredient (API) in detail. Different forms of Ketanest DMFs exist exist since differing nations have different regulations, such as Ketanest USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ketanest DMF submitted to regulatory agencies in the US is known as a USDMF. Ketanest USDMF includes data on Ketanest's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ketanest USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ketanest suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Ketanest Drug Master File in Japan (Ketanest JDMF) empowers Ketanest API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Ketanest JDMF during the approval evaluation for pharmaceutical products. At the time of Ketanest JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Ketanest suppliers with JDMF on PharmaCompass.
A Ketanest CEP of the European Pharmacopoeia monograph is often referred to as a Ketanest Certificate of Suitability (COS). The purpose of a Ketanest CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Ketanest EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Ketanest to their clients by showing that a Ketanest CEP has been issued for it. The manufacturer submits a Ketanest CEP (COS) as part of the market authorization procedure, and it takes on the role of a Ketanest CEP holder for the record. Additionally, the data presented in the Ketanest CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Ketanest DMF.
A Ketanest CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Ketanest CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Ketanest suppliers with CEP (COS) on PharmaCompass.
A Ketanest written confirmation (Ketanest WC) is an official document issued by a regulatory agency to a Ketanest manufacturer, verifying that the manufacturing facility of a Ketanest active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ketanest APIs or Ketanest finished pharmaceutical products to another nation, regulatory agencies frequently require a Ketanest WC (written confirmation) as part of the regulatory process.
click here to find a list of Ketanest suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ketanest as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ketanest API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ketanest as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ketanest and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ketanest NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ketanest suppliers with NDC on PharmaCompass.
Ketanest Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ketanest GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ketanest GMP manufacturer or Ketanest GMP API supplier for your needs.
A Ketanest CoA (Certificate of Analysis) is a formal document that attests to Ketanest's compliance with Ketanest specifications and serves as a tool for batch-level quality control.
Ketanest CoA mostly includes findings from lab analyses of a specific batch. For each Ketanest CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ketanest may be tested according to a variety of international standards, such as European Pharmacopoeia (Ketanest EP), Ketanest JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ketanest USP).